Key result
Self-reporting measures BDI-II and PHQ-9 were equivalent to clinician-rated HRSD for assessing depression in CAD patients, while HADS significantly underestimated depressive symptoms.
Why the study?
Do self-reporting measures (BDI-II, HADS, SSAI/STAI, PHQ) yield equivalent results to clinician-rated instruments (HRSD) for screening depression and anxiety in patients with stable CAD?
Cross-Sectional (n=120)
Do self-reporting measures (BDI-II, HADS, SSAI/STAI, PHQ) yield equivalent results to clinician-rated instruments (HRSD) for screening depression and anxiety in patients with stable CAD?
The HADS scale significantly underestimates depression symptoms in CAD patients compared to other tools like HRSD, BDI-II, and PHQ-9, though it performs similarly for anxiety.
No takes yet. Share an insight, caveat, or question.
May guide depression screening tool selection in CAD; hypothesis-generating and requires larger validation studies.
Moryś et al. (2015) conducted a cross-sectional in stable coronary artery disease (CAD) (n=120). Self-reporting measures (BDI-II, HADS, SSAI/STAI, PHQ) vs. Clinician-rating instrument (HRSD) was evaluated on Depressive and anxiety symptoms. Self-reporting measures BDI-II and PHQ-9 were equivalent to clinician-rated HRSD for assessing depression in CAD patients, while HADS significantly underestimated depressive symptoms.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: